This medical device record is a pma supplement. A supplement may have changed the device description/function or indication from that approved in the original pma. Be sure to look at the original pma record for more information.
Device | Alinity m HBV |
Generic Name | Hepatitis Viral B Dna Detection |
Applicant | Abbott Molecular, Inc.1300 E Touhy Avedes Plaines, IL 60018 PMA NumberP200013 Supplement NumberS006 Date Received02/17/2022 Decision Date03/14/2022 Product Code MKT Advisory Committee Microbiology Supplement Type30-day Notice Supplement Reason Process Change - Manufacturer/sterilizer/packager/supplier Expedited Review Granted? No |
Date Received | 2022-02-17 |
Decision Date | 2022-03-14 |
PMA | P200013 |
Supplement | S006 |
Product Code | MKT |
Advisory Committee | Microbiology |
Supplement Type | 30-day Notice |
Supplement Reason | Process Change - Manufacturer/sterilizer/packager/supplier |
Expedited Review | No |
Combination Product | No |
Applicant Address | Abbott Molecular, Inc. 1300 E Touhy Ave des Plaines, IL 60018 PMA NumberP200013 Supplement NumberS006 Date Received02/17/2022 Decision Date03/14/2022 Product Code MKT Advisory Committee Microbiology Supplement Type30-day Notice Supplement Reason Process Change - Manufacturer/sterilizer/packager/supplier Expedited Review Granted? No Combination ProductNo Approval Order Statement to Extend The Expiration Date Of A Critical Raw Material |
Supplement Number | Date | Supplement Type |
---|---|---|
P200013 | Original Filing | |
S012 | 2022-12-20 | 30-day Notice |
S011 | 2022-12-07 | Special (immediate Track) |
S010 | ||
S009 | 2022-09-21 | Special (immediate Track) |
S008 | 2022-05-10 | 30-day Notice |
S007 | ||
S006 | 2022-02-17 | 30-day Notice |
S005 | 2021-04-15 | Real-time Process |
S004 | 2021-02-05 | 30-day Notice |
S003 | 2021-02-05 | 30-day Notice |
S002 | ||
S001 | 2020-12-21 | 30-day Notice |